Episode 1: Harnessing Data for Better Living Through Data

Andie Cartwright

Welcome to the Better Living Through Data podcast. I'm your host, Andie Cartwright and today I would like to tell you a little about PointClickCare Life Sciences and how important data like ours is revolutionizing care for aging and vulnerable populations. When we talk about improving healthcare outcomes, especially for aging and vulnerable populations, the foundation of it all—really—is data. PointClickCare’s datasets represent an unparalleled resource in this regard. I mean, we’re looking at more than 20 million unique patients and billions of data points. And these aren’t just static; they’re continuously updated, week after week.

Andie Cartwright

And that’s what makes it so powerful. It’s not just about the size of the dataset—it’s how dynamic it is. Like, we're talking near real-time updates. That kind of continuity means researchers and healthcare providers can make decisions based on the most accurate, up-to-date information possible.

Andie Cartwright

The insights we can draw from this data are transformative. For example, tracking vitals like blood pressure, oxygen saturation, or daily activities such as mobility scores—it’s all there. This depth allows healthcare professionals to not only treat conditions more effectively but also anticipate them. It’s all about being proactive, not reactive.

Andie Cartwright

It's also huge for research. Think about clinical trials, for instance. This data supports decisions like site selection for studies or understanding adverse events better. It’s reshaping how trial planning happens.

Andie Cartwright

And there’s more to it than just trials. Policymakers can leverage this information as well—to predict trends, allocate resources effectively, and ensure that care standards are improving for this growing demographic. We know that by 2050 the population aged 65 and over is set to double in the United States. That comes with a massive increase in the prevalence of age-related diseases like Alzheimer’s and Parkinson’s.

Andie Cartwright

Institutions, whether they’re hospitals, research centers, or even drug companies, can’t afford to work with outdated or incomplete data. Updated insights make all the difference in patient care, especially with these kinds of chronic or long-term conditions.

Andie Cartwright

And that’s where having such granular data is key. From vitals tracking to clinical outcomes, this level of visibility allows healthcare innovators to design better solutions and ultimately improve lives.

Andie Cartwright

It’s fascinating to see how targeted insights, especially in diseases like Alzheimer's, are revolutionizing care. Instead of waiting for symptoms to manifest, we’re now uncovering strategies that anticipate disease progression through data.

Andie Cartwright

And when you think about conditions like Parkinson’s, too, it’s remarkable—data is redefining early intervention strategies. A lot of that has to do with being able to follow patients longitudinally over years or even decades. For instance, one project PCC Life Sciences was involved in, uncovered a distinct pattern of symptom onset when reviewing thousands of patient records. This pattern helped inform a new framework for diagnosing early-stage Alzheimer’s.

Andie Cartwright

We have identified trends in behavioral and cognitive markers that hadn’t been previously connected. And because the dataset was continuously updated, researchers could validate those findings almost in real-time. It was a breakthrough moment, not just for the team but for how we approach these diseases. When you add data from daily vitals—like mobility scores or respiration rates—it paints a complete picture of how these conditions evolve.

Andie Cartwright

This isn’t just about better understanding diseases; it's also about addressing the growing demand. Like we said earlier, the 65+ population in the U.S. is going to double by 2050. That demand is going to push healthcare systems to their limits.

Andie Cartwright

To handle that, we have to shift our mindsets. Traditionally, care has been about reacting to illnesses. What this data brings to the table is a proactive approach—anticipating where care is needed, minimizing unnecessary hospitalizations, and, perhaps most importantly, improving quality of life. Our aging demographic deserves nothing less.

Andie Cartwright

And it’s not just about the patients. By providing that level of detail, we’re actually equipping healthcare providers with the tools they need to make better decisions. The ripple effects of that are huge, from public health planning to even how resources get allocated.

Andie Cartwright

This is why integration of these insights into healthcare strategies is so critical. It’s the difference between simply treating one patient at a time versus addressing systemic inefficiencies and improving outcomes across the board.

Andie Cartwright

Building on how data has reshaped patient care and disease management, it’s worth noting how transformative it is in drug development and commercialization as well. One of the biggest challenges in those areas has always been uncertainty. But comprehensive, detailed, and continuously updated data changes all of that. PointClickCare Life Sciences’ datasets allow companies to make more informed decisions, whether they’re designing their clinical trials or planning a market launch.

Andie Cartwright

If we go back to thinking about clinical trial site selection. With this depth in the data, researchers can determine where they’re going to find the right participants. And it’s not just about geographic locations. It’s also about understanding patient demographics, disease prevalence, and all of the layers involved that you need to plan effectively.

Andie Cartwright

By filtering patient groups based on specific criteria like comorbidities or disease progression stages, the trial can target cohorts most likely to yield meaningful results. That precision doesn’t just improve outcomes—it reduces costs and time as well.

Andie Cartwright

And then add in the fact that this data can uncover underdiagnosed conditions. That’s such a game changer. For example, if datasets reveal patterns in prescription switching or off-label prescribing trends, it can highlight conditions that were maybe missed or misunderstood.

Andie Cartwright

Those insights then flow directly into optimizing treatment strategies. Drug companies can see what’s working, what’s not, and pivot strategies much faster. It’s no longer about just introducing a drug and hoping it fits; now, it’s tailored to the nuances of specific populations’ needs.

Andie Cartwright

And that’s where the commercialization part comes in. These datasets allow for incredibly refined strategies—like pinpointing which groups need more awareness or which prescribing patterns should be targeted. It’s like giving the whole process this strategic GPS.

Andie Cartwright

Ultimately, what this data allows us to do is close the loop. From research to trials to launch, these insights create a feedback system that benefits everyone—patients, providers, researchers, and even policymakers. It’s a holistic way to innovate while keeping patient care at the center.

Andie Cartwright

This isn’t just data for data’s sake—it’s about improving lives. And honestly, that’s the most exciting part—knowing that these tools are making a tangible difference in healthcare.

Andie Cartwright

I think that’s a perfect place to wrap up. Thanks to our listeners for tuning in. And to everyone out there, stay curious, stay informed, and we’ll catch you next time.